COVID-19 Vaccine 2021 - What is the Link Between Pharmacovigilance and Building Confidence Around COVID-19 Vaccines?
Topics/Call fo Papers
Who Should Attend?
This webinar will benefit those involved in drug safety, pharmacovigilance, regulatory affairs and medical affairs with relevant areas of expertise and job titles, including:
Drug Safety and Pharmacovigilance Professionals
Head of PV
Safety Operations Leaders
Safety Risk Management
Patient Safety Specialists
Qualified Persons for Pharmacovigilance (QPPV)
Safety Scientists
Medical Affairs Leaders
Regulatory Affairs Professionals
Innovation Leaders
Scientific Officers
Medical Media Professionals
What You Will Learn
In this webinar participants will learn about:
What are the main hesitancy factors against receiving a COVID vaccine and how this closely relates to modern PV & safety operations
What activities and resources ICON is deploying to build confidence in COVID-19 vaccines
Why these activities are essential to resolve the public health crisis
This webinar will benefit those involved in drug safety, pharmacovigilance, regulatory affairs and medical affairs with relevant areas of expertise and job titles, including:
Drug Safety and Pharmacovigilance Professionals
Head of PV
Safety Operations Leaders
Safety Risk Management
Patient Safety Specialists
Qualified Persons for Pharmacovigilance (QPPV)
Safety Scientists
Medical Affairs Leaders
Regulatory Affairs Professionals
Innovation Leaders
Scientific Officers
Medical Media Professionals
What You Will Learn
In this webinar participants will learn about:
What are the main hesitancy factors against receiving a COVID vaccine and how this closely relates to modern PV & safety operations
What activities and resources ICON is deploying to build confidence in COVID-19 vaccines
Why these activities are essential to resolve the public health crisis
Other CFPs
- What is the Link Between Pharmacovigilance and Building Confidence Around COVID-19 Vaccines?
- Utilising a Virtual Central Laboratory Approach to Balance the Delivery, Budget and Risk for Clinical Trials
- Whole-Body MRI Composite Scoring in Neuromuscular Disease Research & Muscle Health
- How to Optimize Customs Taxes for Clinical Trials in Eastern Europe
- How to Successfully Conduct Overseas Clinical Trials as a Small-Medium Sized Biopharmaceutical Company
Last modified: 2021-11-18 04:21:23